Anti-Inflammatory Drugs Market Report 2026
Download Free Sample Buy Now
Anti-Inflammatory Drugs Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anti-Inflammatory Drugs Market Report 2026

Global Outlook – By Drug Class (Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes), By Route of Administration (Parenteral, Oral, Topical, Inhalation), By Applications (Autoimmune Diseases, Respiratory Diseases, Other Diseases), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Anti-Inflammatory Drugs Market Overview

• Anti-Inflammatory Drugs market size has reached to $152.08 billion in 2025

• Expected to grow to $252.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%

• Growth Driver: The Rising Prevalence Of Arthritis Is Fueling The Market Growth Due To Increasing Aging Populations And Musculoskeletal Conditions

• Market Trend: Advancement in Next-Generation Anti-Inflammatory Therapeutics

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anti-Inflammatory Drugs Market?

Anti-inflammatory drugs are a class of medications that reduce inflammation, pain, fever, and swelling by interfering with the body’s natural inflammatory response. These drugs work by inhibiting the action or production of chemical messengers such as prostaglandins, leukotrienes, and cytokines, which are involved in triggering and sustaining inflammation.

The main drug classes of anti-inflammatory drugs are steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics and biosimilars, and others. Steroids are anti-inflammatory medications that mimic natural hormones and are used to treat conditions such as asthma, arthritis, and allergies. They can be administered through various routes, including parenteral, oral, topical, and inhalation. These drugs are used for a range of applications, such as autoimmune diseases, respiratory diseases, and other conditions. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Anti-Inflammatory Drugs Market Global Report 2026 Market Report bar graph

What Is The Anti-Inflammatory Drugs Market Size and Share 2026?

The anti-inflammatory drugs market size has grown rapidly in recent years. It will grow from $152.08 billion in 2025 to $168.74 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to arthritis prevalence, nsaid usage, hospital prescribing, autoimmune disease burden, steroid therapy adoption.

What Is The Anti-Inflammatory Drugs Market Growth Forecast?

The anti-inflammatory drugs market size is expected to see rapid growth in the next few years. It will grow to $252.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to biologic innovation, biosimilar penetration, aging population, autoimmune disease growth, precision medicine adoption. Major trends in the forecast period include growing use of biologics and biosimilars, expansion of chronic inflammatory disease treatment, shift toward targeted anti-inflammatory therapies, growth of topical and localized formulations, increased focus on long-term safety.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Anti-Inflammatory Drugs Market Segmentation

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Is The Driver Of The Anti-Inflammatory Drugs Market?

The rising prevalence of arthritis is expected to propel the growth of the anti-inflammatory drugs market going forward. Arthritis refers to the inflammation of one or more joints, causing pain, swelling, and stiffness that can worsen with age. The rising prevalence of arthritis is primarily due to aging populations as people grow older, the natural wear and tear on joints increases, resulting to a higher likelihood of developing arthritis. Anti-inflammatory drugs help manage arthritis by reducing joint inflammation and pain, allowing patients to maintain better mobility and perform daily activities with greater ease, ultimately improving their overall quality of life. For instance, in July 2024, according to Restored CDC, a US-based nonprofit health information body, an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis is driving the growth of the anti-inflammatory drugs industry.

Key Players In The Global Anti-Inflammatory Drugs Market

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Global Anti-Inflammatory Drugs Market Trends and Insights

Major companies operating in the anti-inflammatory drugs market are focusing on developing innovative solutions, such as next-generation corticosteroid alternatives, to meet the rising demand for safer long-term anti-inflammatory therapies. A next-generation corticosteroid alternative is a therapy engineered to retain glucocorticoid anti-inflammatory effects while reducing adverse outcomes commonly associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, received US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to deliver anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to traditional corticosteroids like prednisone and deflazacort, it offers a more favorable safety profile while maintaining therapeutic benefits. It is used to manage chronic muscle inflammation in children aged two years and older with Duchenne muscular dystrophy.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Anti-Inflammatory Drugs Market?

In October 2023, Amgen, a US-based biopharmaceutical company, acquired Horizon Therapeutics for approximately US$ 27.8 billion. Through this acquisition, Amgen aims to strengthen its portfolio in autoimmune and severe inflammatory diseases by integrating Horizon’s therapies, including TEPEZZA, KRYSTEXXA, and UPLIZNA, and expanding its presence in the treatment of rare and chronic inflammatory conditions. Horizon Therapeutics is an Ireland-based biopharmaceutical company specializing in therapies for rare inflammatory and autoimmune diseases.

Regional Insights

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market consists of sales of immunosuppressants, COX-2 inhibitors, interleukin inhibitors, and TNF-alpha inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-Inflammatory Drugs Market Report 2026?

The anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-inflammatory drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anti-Inflammatory Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $168.74 billion
Revenue Forecast In 2035 $252.87 billion
Growth Rate CAGR of 11.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route of Administration, Applications, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Ind
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anti-Inflammatory Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anti-Inflammatory Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anti-Inflammatory Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anti-Inflammatory Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Use Of Biologics And Biosimilars

4.2.2 Expansion Of Chronic Inflammatory Disease Treatment

4.2.3 Shift Toward Targeted Anti-Inflammatory Therapies

4.2.4 Growth Of Topical And Localized Formulations

4.2.5 Increased Focus On Long-Term Safety

5. Anti-Inflammatory Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Specialty Rheumatology Centers

5.4 Retail Pharmacies

5.5 Online Pharmacies

6. Anti-Inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Inflammatory Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-Inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anti-Inflammatory Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anti-Inflammatory Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anti-Inflammatory Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Inflammatory Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Inflammatory Drugs Market Segmentation

9.1. Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

9.2. Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parenteral, Oral, Topical, Inhalation

9.3. Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autoimmune Diseases, Respiratory Diseases, Other Diseases

9.4. Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

9.5. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Mineralocorticoids

9.6. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

9.7. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

9.8. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

10. Anti-Inflammatory Drugs Market Regional And Country Analysis

10.1. Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Inflammatory Drugs Market

11.1. Asia-Pacific Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Inflammatory Drugs Market

12.1. China Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Inflammatory Drugs Market

13.1. India Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Inflammatory Drugs Market

14.1. Japan Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Inflammatory Drugs Market

15.1. Australia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Inflammatory Drugs Market

16.1. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Inflammatory Drugs Market

17.1. South Korea Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Inflammatory Drugs Market

18.1. Taiwan Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Inflammatory Drugs Market

19.1. South East Asia Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Inflammatory Drugs Market

20.1. Western Europe Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Inflammatory Drugs Market

21.1. UK Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Inflammatory Drugs Market

22.1. Germany Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Inflammatory Drugs Market

23.1. France Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Inflammatory Drugs Market

24.1. Italy Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Inflammatory Drugs Market

25.1. Spain Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Inflammatory Drugs Market

26.1. Eastern Europe Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Inflammatory Drugs Market

27.1. Russia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Inflammatory Drugs Market

28.1. North America Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Inflammatory Drugs Market

29.1. USA Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Inflammatory Drugs Market

30.1. Canada Anti-Inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Inflammatory Drugs Market

31.1. South America Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Inflammatory Drugs Market

32.1. Brazil Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Inflammatory Drugs Market

33.1. Middle East Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Inflammatory Drugs Market

34.1. Africa Anti-Inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Inflammatory Drugs Market Regulatory and Investment Landscape

36. Anti-Inflammatory Drugs Market Competitive Landscape And Company Profiles

36.1. Anti-Inflammatory Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anti-Inflammatory Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anti-Inflammatory Drugs Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Inflammatory Drugs Market Other Major And Innovative Companies

Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

38. Global Anti-Inflammatory Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Inflammatory Drugs Market

40. Anti-Inflammatory Drugs Market High Potential Countries, Segments and Strategies

40.1 Anti-Inflammatory Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Anti-Inflammatory Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Anti-Inflammatory Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anti-Inflammatory Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anti-Inflammatory Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anti-Inflammatory Drugs Market, Supply Chain Analysis
  • Table 4: Global Anti-Inflammatory Drugs Market, Major Raw Material Providers
  • Table 5: Global Anti-Inflammatory Drugs Market, Major Resource Providers
  • Table 6: Global Anti-Inflammatory Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anti-Inflammatory Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Anti-Inflammatory Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Anti-Inflammatory Drugs Market, Major Trends
  • Table 10: Global Anti-Inflammatory Drugs Market, Major End Users
  • Table 11: Global Anti-Inflammatory Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anti-Inflammatory Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anti-Inflammatory Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anti-Inflammatory Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Anti-Inflammatory Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Anti-Inflammatory Drugs Market - Company Scoring Matrix
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Bayer AG Financial Performance
  • Table 102: Novartis AG Financial Performance
  • Table 103: Sanofi S.A. Financial Performance
  • Table 104: Global Anti-Inflammatory Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Anti-Inflammatory Drugs Market, Competitive Dashboard
  • Table 106: Global Anti-Inflammatory Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 108: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 109: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Applications, 2025 – 2030

List Of Figures

    Figure 1: Global Anti-Inflammatory Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anti-Inflammatory Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anti-Inflammatory Drugs Market, Supply Chain Analysis
  • Figure 4: Global Anti-Inflammatory Drugs Market, Major Raw Material Providers
  • Figure 5: Global Anti-Inflammatory Drugs Market, Major Resource Providers
  • Figure 6: Global Anti-Inflammatory Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anti-Inflammatory Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Anti-Inflammatory Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Anti-Inflammatory Drugs Market, Major Trends
  • Figure 10: Global Anti-Inflammatory Drugs Market, Major End Users
  • Figure 11: Global Anti-Inflammatory Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anti-Inflammatory Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anti-Inflammatory Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anti-Inflammatory Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Anti-Inflammatory Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Anti-Inflammatory Drugs Market - Company Scoring Matrix
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Bayer AG Financial Performance
  • Figure 102: Novartis AG Financial Performance
  • Figure 103: Sanofi S.A. Financial Performance
  • Figure 104: Global Anti-Inflammatory Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Anti-Inflammatory Drugs Market, Competitive Dashboard
  • Figure 106: Global Anti-Inflammatory Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 108: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 109: Global, Anti-Inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Applications, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Rheumatology Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes), By Dist...

Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Global Outlook – By Route Of Administration (Oral, Topical, Other Route Of Administration), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Othe...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Rheumatoid Arthritis Drugs Market Report 2026 - Global Outlook – By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (...

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Global Outlook – By Route Of Administration (Oral, Topical, Other Route Of Administration), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Othe...

Antiglaucoma Drugs Market Report 2026 - Global Outlook – By Mode Of Availability (Hospital Prescription Drugs, Non-Prescription Drugs), By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medic...

Frequently Asked Questions

The Anti-Inflammatory Drugs market was valued at $152.08 billion in 2025, increased to $168.74 billion in 2026, and is projected to reach $252.87 billion by 2030.

The global Anti-Inflammatory Drugs market is expected to grow at a CAGR of 10.6% from 2026 to 2035 to reach $252.87 billion by 2035.

Some Key Players in the Anti-Inflammatory Drugs market Include, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited .

Major trend in this market includes: Advancement in Next-Generation Anti-Inflammatory Therapeutics . For further insights on this market. request a sample here

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us